Menu
We are currently in the application process to list on a public stock exchange and will make appropriate announcement when achieved.
Our objective is to maximize value for stakeholders and provide investors with liquidity with an attractive exit strategy.
An exchange listing will also ensure transparency and allow further funds to be raised to build out additional units and for business development.
We expect that as one of the first cannabis companies to be listed on a European exchange, we can reach a significant market capitalization within the next 24 months.
Our dedicated team of expert growers and researchers will continuously develop proprietary strains of cannabis to suit specific needs of the medical cannabis market.
We will utilize nano technology, genome studies, and other advanced technologies to produce unique cannabis products. Our growers and researchers are developing the world’s most complete and complex cannabis strains. They have spent years honing their skills and knowledge while working throughout an array of cannabis ventures for numerous companies both internationally and nationally here in Denmark.
Our seed segment expects to focus primarily on producing cannabis seeds for wholesale distribution to medical caretakers and commercial medical growers as well as pharmaceutical companies.